Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Photo Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104844651A enables green synthesis of fluorinated phenanthridine derivatives with mild conditions, reducing waste and enhancing supply chain reliability for fine chemical manufacturing.
Novel visible light-mediated synthesis achieves high-purity API intermediates with mild conditions and scalable production for reliable supply chain.
Patent CN110590788B enables high-purity 2-acyl-pyrroloindole API intermediates through visible-light catalysis, reducing manufacturing costs and lead times.
Novel visible-light catalyzed synthesis of 3-aryl-2H-indazoles enables high-purity pharmaceutical intermediates with reduced manufacturing costs and faster scale-up.
Reduce production costs and metal residues with this efficient photocatalytic route for high-purity o-amino aromatic ketones in drug development.
Discover how visible light photocatalysis enables 90% yield in fluoroalkyl heterocycle synthesis, eliminating high-pressure equipment and reducing supply chain risks for pharmaceutical intermediates.
Discover how visible light photocatalysis enables safer, higher-yield synthesis of 3-acyl spirotrienones for pharmaceutical intermediates. Reduce supply chain risks.
Discover a 75-96% yield, room-temperature synthesis of 1,3,4-oxadiazole derivatives. Eliminate metal residues and toxic reagents for safer, cost-effective API manufacturing.
Eliminate toxic reagents and noble metals in tetracyclic quinazolinone production with 83% yield. Scale to 100MT/yr with NINGBO INNO PHARMCHEM's CDMO expertise.
Solve metal residue issues in 3-thioindole production with metal-free photocatalysis. Achieve 70% yield, simplified process, and GMP compliance for your drug development projects.
Solve high-cost catalyst issues in indoloisoquinolinone synthesis. This metal-free, visible-light method offers 60-72% yield with easy scale-up for drug development.
Discover how metal-free photoredox catalysis enables high-yield, enantioselective synthesis of chiral thiochroman-4-ketones for anticancer drug development. Reduce supply chain risks and GMP compliance costs.
Discover how metal-free photoredox catalysis enables high-yield, enantioselective synthesis of chiral chroman-4-ones for anticancer drug development. Reduce supply chain risks and improve purity.
Discover how photocatalytic N-alpha arylation eliminates HAT reagents, reduces costs, and achieves 99% purity for pharmaceutical intermediates. Scale to 100 MT/annual with CDMO expertise.
Solve supply chain risks with metal-free synthesis of brominated BCPs. High-yield, green process for drug development. Contact for custom synthesis.
Discover how visible light photocatalysis enables high-yield, metal-free synthesis of difluoromethyl aldehyde hydrazones, reducing costs and supply chain risks for pharmaceutical intermediates.
Solve metal residue issues in 3-thioindole production. 70% yield, no transition metals, room-temperature process. CDMO expertise for scalable API synthesis.
Discover how nickel/photo-redox catalysis enables 78-83% yield in C-H cross-coupling for pharmaceutical intermediates with 99:1 regioselectivity. Reduce production costs and supply chain risks.
Solve high-temperature synthesis challenges with this metal-free photocatalytic method. Achieve 89% yield, reduced costs, and simplified purification for your API production.
Discover how photoredox catalysis of linear tertiary alcohols reduces production costs by 30% while expanding designability for drug intermediates and agrochemicals. Scale-ready solutions for R&D and procurement teams.